These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35449173)

  • 41. Prediction of the inhibition of IL-2 production by calcineurin inhibitors.
    van den Berg AP; van Son WJ; Haagsma EB; The TH; Slooff MJ; de Leij LM
    Transplant Proc; 2001; 33(1-2):1076-7. PubMed ID: 11267197
    [No Abstract]   [Full Text] [Related]  

  • 42. Tacrolimus and cyclosporine A are of no benefit to young rats with kaolin-induced hydrocephalus.
    Khan OH; Enno T; Del Bigio MR
    Pediatr Neurosurg; 2003 Dec; 39(6):309-13. PubMed ID: 14734865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus.
    Jørgensen KA; Koefoed-Nielsen PB; Karamperis N
    Scand J Immunol; 2003 Feb; 57(2):93-8. PubMed ID: 12588654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors.
    Yano I
    Drug Metab Pharmacokinet; 2008; 23(3):150-7. PubMed ID: 18574318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat.
    Moia LJ; Matsui H; de Barros GA; Tomizawa K; Miyamoto K; Kuwata Y; Tokuda M; Itano T; Hatase O
    Brain Res; 1994 Jun; 648(2):337-41. PubMed ID: 7522929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
    Salowe SP; Hermes JD
    Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain.
    Yu DY; Luo J; Bu F; Zhang W; Wei Q
    IUBMB Life; 2006 Jul; 58(7):429-33. PubMed ID: 16801218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.
    Harrison CA; Bastan R; Peirce MJ; Munday MR; Peachell PT
    Br J Pharmacol; 2007 Feb; 150(4):509-18. PubMed ID: 17200674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology of calcineurin antagonists.
    Kapturczak MH; Meier-Kriesche HU; Kaplan B
    Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.
    Gardiner SM; March JE; Kemp PA; Fallgren B; Bennett T
    Br J Pharmacol; 2004 Feb; 141(4):634-43. PubMed ID: 14744807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition.
    Uchino H; Minamikawa-Tachino R; Kristián T; Perkins G; Narazaki M; Siesjö BK; Shibasaki F
    Neurobiol Dis; 2002 Aug; 10(3):219-33. PubMed ID: 12270685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.
    Jin L; Harrison SC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13522-6. PubMed ID: 12357034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive.
    Miyata H; Satouh Y; Mashiko D; Muto M; Nozawa K; Shiba K; Fujihara Y; Isotani A; Inaba K; Ikawa M
    Science; 2015 Oct; 350(6259):442-5. PubMed ID: 26429887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
    Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
    Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.
    Werneck MB; Hottz E; Bozza PT; Viola JP
    Cell Cycle; 2012 Nov; 11(21):3997-4008. PubMed ID: 22992618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.